Analysis of the vascular responses in a murine model of polycystic ovary syndrome
Authors:
- E Leonie A F van HoutenEHE Leonie A F van Houten
- René de VriesRVRené de Vries
- Usha M Musterd-BagghoeUMUsha M Musterd-Bagghoe
- Ingrid M GarreldsIGIngrid M Garrelds
- Piet KramerPKPiet Kramer
- A H Jan DanserADA H Jan Danser
- Carlos M VillalónCVCarlos M Villalón
- Jenny A VisserJVJenny A Visser
- Antoinette MaassenVanDenBrinkAMAntoinette MaassenVanDenBrink
- 3 June 2013
- journal article
- Published by Bioscientifica in Journal of Endocrinology
- Vol. 218 (2) , 205-213
Abstract
Polycystic ovary syndrome (PCOS) is the most common endocrine disorder in women of the reproductive age, but the exact pathophysiological mechanisms involved remain unclear. Cardiovascular disease risk is increased in PCOS patients and endothelial damage has been observed. We recently developed a mouse model of PCOS with reproductive and metabolic characteristics resembling those observed in women with PCOS. In this model we studied vascular function with particular emphasis on markers of vascular endothelial function. Animals were treated for 90 days with dihydrotestosterone (DHT; 27.5 μg/day) or placebo using subcutaneous continuous-release pellets. Aortas were isolated for isometric force recordings in organ baths to investigate endothelial and vascular smooth muscle characteristics. Lungs were used to analyze endothelial nitric oxide synthase (eNOS) expression and phosphorylation. Asymmetric dimethylarginine (ADMA) levels were investigated in serum to assess endothelial damage. Expression of androgen receptor (Ar) mRNA was studied in aortas. DHT treatment (compared with placebo) induced i) a significant decrease in acetylcholine-induced aortic relaxations, with no change in calcitonin gene-related peptide- or sodium nitroprusside-induced relaxations, as well as 5-hydroxytryptamine-induced contractions; ii) no change in eNOS expression/phosphorylation in lungs or in plasma ADMA levels; and iii) a twofold increase in aortic AR expression. Our results suggest that, in DHT-exposed mice, hyperandrogenemia specifically decreases endothelium-dependent vasorelaxation without deterioration of smooth muscle function. This study may initiate further investigations to elucidate underlying mechanism for the phenotype that is present in these animals, as well as in PCOS patients.Keywords
This publication has 46 references indexed in Scilit:
- Nucleotide Excision DNA Repair Is Associated With Age-Related Vascular DysfunctionCirculation, 2012
- Paraoxonase lactonase activity (PON-HTLase), asymmetric dimethylarginine (ADMA) and platelet activating factor-acetylhydrolase (PAF-AH) activity in non-obese women with PCOSGynecological Endocrinology, 2012
- Possible sites of action of the new calcitonin gene-related peptide receptor antagonistsTherapeutic Advances in Neurological Disorders, 2010
- Molecular cell biology of androgen receptor signallingThe International Journal of Biochemistry & Cell Biology, 2010
- The administration of estrogens, combined with anti-androgens, has beneficial effects on the hormonal features and asymmetric dimethyl-arginine levels, in women with the polycystic ovary syndromeAtherosclerosis, 2008
- Relative Prevalence of Different Androgen Excess Disorders in 950 Women Referred because of Clinical HyperandrogenismThe Journal of Clinical Endocrinology & Metabolism, 2006
- The Prevalence and Features of the Polycystic Ovary Syndrome in an Unselected PopulationThe Journal of Clinical Endocrinology & Metabolism, 2004
- Preliminary indication of a high prevalence of polycystic ovary syndrome in indigenous Australian womenGynecological Endocrinology, 2002
- A Prospective Study of the Prevalence of the Polycystic Ovary Syndrome in Unselected Caucasian Women from SpainThe Journal of Clinical Endocrinology & Metabolism, 2000
- A Survey of the Polycystic Ovary Syndrome in the Greek Island of Lesbos: Hormonal and Metabolic ProfileThe Journal of Clinical Endocrinology & Metabolism, 1999